Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ilayda Gercik Arzik has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors Determining a Recommendation for Termination of Pregnancy in the Presence of Fetal Renal Anomalies

    by Abdulmecit Oktem, İlayda Gercik Arzik, Mukremin Ceylan, Zübeyde Emiralioglu Cakir, Orhan Nural, Atalay Ekin

    Background/Objectives: To identify the clinical factors associated with a multidisciplinary fetal council’s recommendation for termination of pregnancy in fetuses with renal anomalies, to describe how often families followed this recommendation, and to describe outcomes among continued pregnancies. Methods: This retrospective cohort study included 103 singleton pregnancies with a prenatally diagnosed renal or urinary tract anomaly discussed at a tertiary fetal council between December 2023 and July 2026. Renal severity, gestational age at diagnosis, amniotic fluid status, associated fetal abnormalities, and genetic evaluation were examined in relation to the council recommendation. Independent associations were assessed using multivariable logistic regression, Poisson regression with robust variance estimation, and Firth penalized logistic regression. Postnatal outcomes were summarized for pregnancies that continued. Results: A termination recommendation was issued in 59 of 103 pregnancies (57.3%). Of these, 43 families (72.9%) accepted it and the pregnancy was terminated, whereas 16 (27.1%) continued the pregnancy. Later diagnosis and moderate or low renal severity were independently associated with a lower likelihood of a termination recommendation. The presence of an additional fetal anomaly (adjusted odds ratio [aOR] 8.24, 95% confidence interval [CI] 1.59–42.65) and completion of genetic testing (aOR 4.53, 95% CI 1.45–14.15) were independently associated with a higher likelihood of such a recommendation. Among 60 continued pregnancies, 11 intrauterine or neonatal/postnatal deaths occurred (18.3%); mortality was 42.9% in the high-severity group and 5.3% in the low-severity group. The prenatal renal finding was confirmed postnatally in 22 cases, while renal-specific follow-up was unavailable in 18. Conclusions: Termination recommendations issued after prenatal detection of a renal anomaly were shaped by the timing of diagnosis, expected renal prognosis, the wider fetal phenotype, and the availability of genetic information. The observed difference between the council recommendation and the parental decision, together with substantial variation in postnatal outcomes, supports individualized counseling within a multidisciplinary framework.

  • Perinatal Outcomes of Fetuses with Lower Urinary Tract Obstruction Treated with Vesico-Amniotic Shunting: A Single-Center Experience

    by İlayda Gercik Arzık, Hakan Gölbaşı, Ceren Sağlam Purut, Zübeyde Emiralioğlu Çakır, Hale Ankara Aktaş, İlKnur Toka, Raziye Torun, Mehmet Özer, İlKer Uçar, Atalay Ekin

    Aim:To evaluate perinatal outcomes in fetuses with lower urinary tract obstruction (LUTO) treated with vesico-amniotic shunting (VAS).Methods:This retrospective case series included singleton pregnancies diagnosed with fetal LUTO that underwent VAS placement between January 2020 and January 2026. Prenatal ultrasonographic findings, amniotic fluid dynamics, fetal therapy details, and pregnancy and neonatal outcomes were obtained from medical records. Due to the limited sample size and clinical heterogeneity, analyses were descriptive.Results:Six fetuses with suspected LUTO underwent VAS placement during the study period. Gestational age at initial diagnosis ranged from 12+0 to 28+1 weeks. Longitudinal bladder diameter at diagnosis varied between 15 and 120 mm, reflecting marked heterogeneity in disease severity. Amniotic fluid volume was within normal limits at diagnosis in all cases; however, oligohydramnios developed during follow-up in one fetus. Procedure-related complications occurred in two cases, including shunt dislocation and shunt blockage. Pregnancy outcomes included two live births, two intrauterine fetal demises, one neonatal death related to extreme prematurity, and one elective termination. Both liveborn infants were delivered at more advanced gestational ages and had preserved amniotic fluid volume throughout pregnancy. Postnatal renal function appeared preserved during early neonatal follow-up in these cases.Conclusion:Perinatal outcomes in fetuses with LUTO treated with VAS remain highly variable. Preservation of amniotic fluid volume and sustained shunt function appear to be important factors associated with improved perinatal survival. Careful patient selection and multidisciplinary prenatal counseling are essential when considering fetal intervention in LUTO.

  • Open Access

    Development of Gestational Age-Specific Nomograms for Fetal Splenic Artery Doppler Parameters Between 18 and 40 Weeks of Gestation

    by Ilayda Gercik Arzik, Burak Bayraktar, Zubeyde Emiralioglu Cakir, Hale Ankara Aktas, Ceren Saglam Purut, Hakan Golbasi

    OBJECTIVE: To characterize the gestational age-related behavior of fetal splenic artery (SA) Doppler parameters and to establish appropriate reference models for the systolic/diastolic (S/D) ratio, pulsatility index (PI), peak systolic velocity (PSV), and time-averaged maximum velocity (TAMV) in normal singleton pregnancies between 18 and 40 weeks of gestation. STUDY DESIGN: This prospective observational cross-sectional study included 103 normal singleton pregnancies undergoing routine obstetric ultrasonographic examination between 18 and 40 weeks of gestation. SA Doppler waveforms were obtained using a standardized technique, and the S/D ratio, PI, PSV, and TAMV were recorded. We modeled the relationship between gestational age and each parameter using linear and quadratic regression analysis and derived gestational age-specific Z-score equations and percentile reference values (5th, 10th, 50th, 90th, and 95th). Gestational age-specific modeling was applied to PSV and TAMV; PI, which showed no gestational age dependence, was reported as a single pooled reference interval, and S/D, which could not be adequately modeled parametrically, was reported descriptively. Correlations between SA Doppler parameters and gestational age, fetal biometric parameters, and umbilical artery (UA) Doppler indices were assessed using Spearman correlation analysis. RESULTS: SA PSV and TAMV increased significantly with advancing gestational age (PSV=−5.651+1.587×GA, R²=0.399, p<0.001; TAMV=−10.900+0.929×GA, R²=0.401, p<0.001), whereas the SA S/D ratio and PI showed no significant association with gestational age. SA PSV and TAMV correlated positively with abdominal circumference and estimated fetal weight (r=0.632-0.674, all p<0.001) and negatively with UA Doppler indices. In contrast, SA S/D correlated positively with the UA S/D ratio (r=0.405, p=0.006). CONCLUSION: This study provides gestational age-specific nomograms and Z-score equations for SA PSV and TAMV, a pooled reference interval for SA PI, and descriptive values for SA S/D in normal pregnancy. These reference values may serve as a normative foundation for future research examining SA hemodynamics in relation to fetal growth, anemia, and pancreatic development.

  • Open Access

    The Prevalence of Human Papilloma Virus in Turkish Women

    by Göktürk Han Doğan, Ceren Sağlam Purut, İbrahim Gülhan, İlayda Gercik Arzık, Abdurrahman Hamdi İnan, Muzaffer Sancı, Rumeysa Nur Çağıran, Yunus Emre Purut

    Background/Objectives: The prevalence of Human Papilloma Virus (HPV) in Türkiye may vary from that reported in other countries. Determining the age-specific distribution of HPV infection and its overall prevalence in all tested individuals, supported by a large sample size, would provide valuable insights for HPV prevention programs. This study aims to determine the regional prevalence of HPV infection. Methods: This is a retrospective study containing data from 52,930 patients who underwent HPV testing at a tertiary hospital between 2016 and 2024. Patients aged 21 to 65 were included in the study. Target DNA amplification by polymerase chain reaction (PCR) and nucleic acid hybridization techniques were performed for the identification of HPV. Overall prevalence, age-specific prevalence, and genotype distribution were examined. Results: Analysis of genotype distribution revealed that isolated HPV16 positivity was 4.0% (n = 2118), isolated HPV18 positivity was 1.0% (n = 528), and isolated other high-risk (HR) HPV types (excluding HPV16 and HPV18) were detected in 10.8% (n = 5693) of patients. The co-positivity rates were as follows: HPV16 and HPV18 in 0.4% (n = 237), HPV16 and HR-HPV other in 2.3% (n = 1197), HPV18 and HR-HPV other in 1.0% (n = 513), and HPV16, HPV18, and HR-HPV other in 0.3% (n = 145). Conclusions: This study highlights that HPV positivity is higher among individuals aged 21–24 years in our population, the overall prevalence is broadly consistent with the range reported in previous Turkish and international studies, and the pooled other HR-HPV group was more frequent than HPV16 or HPV18 individually.


  • Open Access

    Comprehensive assessment of hematologic inflammatory indices across all trimesters in intrahepatic cholestasis of pregnancy

    by Zübeyde Emiralioğlu Çakır, İbRahim Ömeroğlu, Dilara Ekici Zincirci, İlayda Gercik Arzık, Raziye Torun, Burcu Ceren Özdoğan, Hasan Baran Livdumlu, Hakan Gölbaşı

    Aims: To evaluate trimester-specific changes in hematologic inflammatory indices in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to determine their potential discriminative performance. Methods: This retrospective case–control study included 84 pregnancies with ICP and 96 healthy controls. Complete blood count parameters obtained in each trimester were used to calculate neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), Systemic Immune-inflammation Index (SII), Systemic Inflammation Response Index (SIRI), pan-immune-inflammation value (PIV), and mean platelet volume (MPV). Groups were compared using appropriate statistical tests. Receiver operating characteristic (ROC) analysis was performed to assess the discriminatory performance of first-trimester indices. Results: Third-trimester body mass index, gestational age at delivery, and birth weight differed significantly between groups (p≤0.001). In trimester-based comparisons, first-trimester neutrophil count, platelet count, NLR, and SII were significantly higher in the ICP group (p=0.042; p=0.011; p=0.005; and p=0.028, respectively). Second-trimester hemoglobin and neutrophil counts were modestly increased in ICP (p=0.038 and p=0.022). In the third trimester, only MPV was significantly elevated in the ICP group (p

  • Open Access

    Fetal Posterior Fossa Anomalies: Diagnosis-Specific Ultrasound–MRI Concordance and Divergent Perinatal Outcomes

    by Raziye Torun, Hakan Golbasi, Mucahit Furkan Balci, Zubeyde Emiralioglu Cakir, Sevim Tuncer Can, Ilayda Gercik Arzik, Hale Ankara Aktas, Ilknur Toka, Atalay Ekin, Ozgur Oztekin

    Background and Objectives: We aimed to examine the demographic characteristics, prenatal imaging findings, genetic evaluation results, and postnatal outcomes of fetuses with posterior fossa anomalies (PFAs), and also to evaluate the diagnostic concordance between prenatal ultrasonography (USG) and fetal magnetic resonance imaging (MRI). Materials and Methods: This descriptive study analyzed singleton pregnancies referred to Izmir City Hospital and Tepecik Training and Research Hospital for suspected fetal PFA between 2016 and 2024. Data including USG findings, fetal MRI reports, genetic results, and perinatal outcomes were extracted from institutional records. Diagnostic concordance between USG and MRI was statistically assessed using the kappa coefficient. Results: Out of 152 fetuses with suspected PFA on USG, 116 underwent fetal MRI. Following the exclusion of normal MRI findings (n = 23), the final cohort comprised 93 fetuses with confirmed PFA. Mega cisterna magna (MCM) was the most prevalent diagnosis (54.8%), followed by cerebellar hypoplasia (CH) (15.1%) and Dandy–Walker malformation (DWM) (10.8%). A moderate-to-good diagnostic concordance was observed between USG and MRI (kappa = 0.640, p < 0.001). Significant differences were noted across MRI groups regarding gestational age at diagnosis (p < 0.001) and birth weight, which was notably lower in CH compared to MCM (p = 0.004). Clinical outcomes varied significantly by diagnosis (p < 0.001); while 74.5% of MCM cases showed normal development, adverse outcomes predominated in CH and Walker–Warburg syndrome. Conclusions: Fetal PFAs are a heterogeneous group of anomalies with different diagnostic and variable prognostic profiles. Fetal MRI improves anatomical classification and provides clinically significant contributions to prenatal counseling and perinatal management.

  • Correlation Between Placental Hormones and Placental Elasticity and the Relationship Between These Parameters and Pregnancy Outcomes

    by Raziye Torun, Hakan Golbasi, Zubeyde Emiralioglu Cakır, Sevim Tuncer Can, Ibrahim Omeroglu, Ceren Saglam Purut, Ilknur Toka, Ilayda Gercik Arzık, Hale Ankara Aktas, Mukremin Ceylan, et al.

    Background: The placenta is an essential organ for regulating maternal‐fetal exchange and hormonal regulation. Mechanical properties such as tissue elasticity and hormonal markers such as pregnancy‐associated plasma protein A (PAPP‐A) and free Beta‐human chorionic gonadotropin (f‐B‐hCG) have been proposed as indicators of placental function, but their combined utility in predicting obstetric outcomes remains uncertain. Objectives: To evaluate the correlation between placental hormones and placental elasticity and to assess the potential utility in predicting adverse pregnancy outcomes. Methods: In this prospective study, 134 pregnant women (16–21 weeks' gestation) underwent placental shear wave elastography (central and peripheral regions). First trimester PAPP‐A and f‐B‐hCG results, maternal demographics, and pregnancy outcomes were collected. Obstetric complications were defined as gestational hypertension, gestational diabetes, intrauterine growth restriction, preterm birth, and low birth weight. Results: Peripheral placental stiffness was significantly higher in women with complications ( p = 0.043), whereas central stiffness did not differ. Maternal age and body mass index (BMI) were also higher in the complication group ( p = 0.001 and p = 0.005, respectively). ROC analysis identified maternal age (76.6% sensitivity and 59.8% specificity with a cut‐off value of 31), BMI (85.1% sensitivity and 37.9% specificity with a cut‐off value of 23.1), and peripheral stiffness (85.1% sensitivity and 34.5% specificity with a cut‐off value of 2.9 (kPa)) as moderate predictors. Analysis showed that gestational age increased the risk of complications (OR = 2.059, p < 0.001), whereas higher BMI paradoxically decreased it (OR = 0.895, p = 0.014). No significant associations were observed between PAPP‐A, f‐B‐hCG, and adverse outcomes. Conclusion: Peripheral placental stiffness measured by shear wave elastography appears to be a promising noninvasive marker for predicting obstetric complications. Although hormonal biomarkers were not predictive in this cohort, larger multicenter studies are needed to evaluate the combined prognostic role of placental markers of biochemical and biomechanical.

  • Open Access

    Association between maternal body mass index and increased fetal pancreatic circumference in normoglycemic pregnancies: a prospective cross-sectional study

    by Ilayda Gercik Arzik, Hakan Golbasi, Hale Ankara Aktas, Zubeyde Emiralioglu Cakir, Ceren Saglam Purut, Burak Bayraktar, Mukremin Ceylan, Eyyup Suer Timur, Atalay Ekin

    To evaluate the association between maternal body mass index (BMI) and fetal pancreatic circumference (PC) in singleton pregnancies without gestational diabetes mellitus (GDM), and to determine whether maternal obesity is related to pancreatic changes independent of conventional fetal growth parameters. This prospective multicenter cross-sectional study included normoglycemic singleton pregnancies assessed in the second (n = 142) and third (n = 154) trimesters. All participants underwent a 75-g oral glucose tolerance test (OGTT), and GDM cases were excluded. Maternal BMI was categorized according to World Health Organization (WHO) criteria. Fetal PC was measured using a standardized freehand tracing technique, and the mean of three measurements was recorded. Comparisons among BMI groups were performed using ANOVA and ANCOVA adjusted for fetal abdominal circumference (AC). Correlation and multivariable logistic regression analyses were conducted to assess associations with composite adverse neonatal outcomes (CANO). Maternal, fetal, and neonatal characteristics, including estimated fetal weight, AC percentile, birth weight, and Apgar scores, were similar across maternal BMI categories. However, fetal PC differed significantly by maternal BMI in both trimesters. In the second trimester, mean PC was 6.44 ± 0.86 cm in normal-weight women, 7.10 ± 0.94 cm in overweight women, and 7.11 ± 0.98 cm in obese women (p = 0.008), remaining significant after AC adjustment (p = 0.021). In the third trimester, PC increased progressively (6.84 ± 0.48 cm, 7.64 ± 0.78 cm, and 7.93 ± 1.04 cm; p = 0.004), persisting after adjustment (p = 0.003). PC correlated positively with maternal BMI, gestational age, and AC. Neither BMI nor PC independently predicted adverse neonatal outcomes. Higher maternal BMI is associated with increased fetal PC independent of conventional growth parameters, suggesting organ-specific intrauterine effects even without GDM. Short-term neonatal outcomes were unaffected.


  • Open Access

    Arterial and Venous Doppler Parameters in Fetal Growth Restriction: A Comparative Evaluation of Early- and Late-Onset Subtypes

    by Hale Ankara Aktas, Ilayda Gercik Arzik, Zubeyde Emiralioglu Cakir, Burak Bayraktar, Bahar Konuralp Atakul, Emre Bayram, Eyyup Suer Timur, Ibrahim Omeroglu, Atalay Ekin, Hakan Golbasi

    Objective: To evaluate and compare fetal arterial and venous Doppler parameters in early-onset (EO) and late-onset (LO) fetal growth restriction (FGR), and to assess their performance within the study cohort and their association with composite adverse neonatal outcome (CANO). Methods: This prospective observational cohort study included 184 singleton pregnancies between 24 and 37 weeks of gestation, comprising 91 FGR cases and 93 appropriate-for-gestational-age controls. FGR was defined according to Delphi consensus criteria and classified as EO-FGR (<32 weeks) or LO-FGR (≥32 weeks). All fetuses underwent standardized Doppler assessment of the umbilical artery (UA), middle cerebral artery (MCA), uterine artery (UtA), and ductus venosus (DV). The cerebroplacental ratio (CPR) was calculated. Multivariable logistic regression models were constructed separately for EO-FGR and LO-FGR. Classification performance was evaluated using receiver operating characteristic analysis. CANO was defined as at least one of the following: 5-min Apgar score <7, respiratory distress syndrome, neonatal intensive care unit admission, or preterm birth. Results: In both EO-FGR and LO-FGR, UA PI values were significantly higher, whereas MCA PI and CPR were significantly lower than in controls. CPR demonstrated the highest discriminative performance among arterial parameters in both subgroups. DV Doppler indices were not significantly different in EO-FGR. In LO-FGR, DV S-wave and v-wave velocities were independently associated with FGR. No significant associations were observed between Doppler parameters and CANO in subgroup analyses. Conclusions: Arterial Doppler parameters, particularly CPR, showed consistent alterations in both EO- and LO-FGR. The contribution of venous Doppler parameters differed according to clinical subtype, with additional value observed in LO-FGR.

  • Open Access

    Lack of Association Between Middle Cerebral Artery Diastolic Deceleration Area and Gestational Diabetes Mellitus: A Prospective Case-Control Study

    by Zubeyde Emiralioglu Cakır, Hale Ankara Aktaş, Ilayda Gercik Arzık, Ceren Saglam, İlker Cakir, İlknur Toka, Mükremin Ceylan, Pınar Tuğçe Özer, Hakan Golbasi

    Backgroud and Objectives: To evaluate conventional Doppler indices and the novel middle cerebral artery (MCA) diastolic deceleration area (DDA) in pregnancies complicated by gestational diabetes mellitus (GDM), and to explore their associations with perinatal outcomes. Prospective case–control study conducted at a tertiary referral perinatology center. Materials and Methods: The study included 83 women with GDM and 92 healthy controls. Standard fetal biometric and Doppler parameters—umbilical artery, MCA, ductus venosus, cerebroplacental ratio, and umbilicocerebral ratio—were assessed, alongside calculation of MCA DDA. Perinatal outcomes were recorded. Results: Most conventional Doppler indices did not differ between groups, except for lower MCA dicrotic notch velocity and higher ductus venosus time-averaged maximum velocity in the GDM group. MCA DDA values did not differ significantly between GDM and control groups (6.67 [5.02–8.20] vs. 7.05 [5.21–8.39] cm·s, p = 0.444) and showed no difference between insulin- and diet-controlled subgroups (p > 0.05). MCA DDA showed significant correlations with gestational age, MCA peak systolic velocity, and birth weight. However, after adjustment for potential confounders, gestational age remained the only independent determinant of MCA DDA. The multivariable analysis evaluating composite adverse neonatal outcomes was limited by the small number of adverse events (n = 14). Conclusions: MCA DDA did not differ between GDM and control pregnancies and primarily reflected gestational age-related physiological variation rather than diabetes specific hemodynamic changes. However, its relationship with adverse neonatal outcomes remains uncertain and requires further investigation in larger prospective studies.